Reason for request
Renewal of inclusion
Clinical Benefit
| Substantial |
the actual benefit of CERVARIX remains substantial only the Marketing Authorisation indications recommended by the HCSP in the current vaccination schedule. |
eNq1mE1z2jAQhu/8Co8PvWHjAAFam0xLk5aZZEoJTDu9MMJegqiRHH3w0V9fGZMGOnLTCHS0Zb+70q4evaPwarNMnRUwjimJ3MCruQ6QmCaYPETueHRTbbtX3Uq4QCt08FnLq3nBhevEKeI8cvNRbwqIcO/73e1HUP8Dc7sVJ6TTBcTi6DspcOp9Rnx+h7L8GydcUZw4SxBzmkRuJsXurRNywVQW3TVlP3mGYgj9/ZvD0cWkcfg+9HOx/1CVHNgtIg9aUSBGmrFkDIjoIQEPlG1L8q0baWM+BE4li2GAxHzA6AonkGhDzFDKwSjIbJ3cA1ulIPIgWnF/ES+5kThaoM0QHvv6pN+r0Z7YiGqtGrRajdplp95udRpNo1DsYKn0VVCT8ONJ0AxanYvAB+LHat6I4Y1hcQaUCZRaKgvmvePOshSHweOL5U8wz1K09RY8M10qxJAaBqb2v72J5DMYMUWkVK3ZX/pEpqn/yqzHe15YyjjHUY9KIkqwcTM0XYgeJQI25RU1I53Y7HsRAz+f7C9K9JQfyGmKY1OmKepI4GI87Jcj7aw0+IA4jJk9HHzDJKFrfn7MHJbVUvbZjpRa0YwlweSi074Mmk3jXfRD9VDJGXMtGc3AVwDC/BSu9MmMnkoU1ZZ6qaemPF8/7qwOjVEKJWanakgX1YhP3sxaq9vbRsWAVvTT9ci0P75KYNv73aNWGifRn8qaodcGz1U3vpR4sW+jbFKvNdudeuMNWmbvnlx0ZOiYC1ErhlkyPWTmQmT8re+v12tvjniVI7We3oz94xS40s79HPNXyH0upz1Tb8UDFJ6owK2l1KfFOfq6Opru3JdcwqnOd///3mFrYwgm4YRaFJC3huL+9fnp/mx7raU9OGKMvTA7i4oEpsSWc5JTreJp54mqK7lhChBfZjNccslS2pehX1zwdCuhn1/udCu/Af6JAjg=
Z9d1Ba7YhmgApWRg
